The NCSS team visited the international CPHI exhibition in Shanghai.

From June 24 to 27, a delegation from NCSS participated in one of the world's largest pharmaceutical industry exhibitions - CPHI China in Shanghai. The event brought together pharmaceutical representatives, leading manufacturers of active pharmaceutical ingredients (APIs), intermediate compounds, and other key industry players.

During the exhibition, NCSS representatives personally met with API manufacturers, discussed current market trends, raw material quality requirements, and cooperation prospects. Participation in CPHI China allowed them not only to study new products and technologies but also to strengthen contacts with key suppliers of pharmaceutical components. In addition to visiting the exhibition, the NCSS team held a series of business meetings in Shanghai, during which they visited production facilities of Chinese partners. This provided an opportunity to assess the level of technological processes, quality standards, and potential for further cooperation on-site.

"Participation in CPHI China and negotiations with manufacturers gave us insight into the current state of the API market," noted Andrey Arkadyevich Berman, General Director of NCSS. "We not only expanded our network of contacts but also verified the capabilities of reliable suppliers, which is crucial for ensuring the quality of pharmaceutical products in Russia." NCSS continues to actively develop international cooperation, contributing to the improvement of standards in the pharmaceutical industry. More details about new projects and partnerships will be covered in upcoming materials.